2025-02-012026-01-312026-01-31false07430397MEDS AT HOME LIMITED2026-07-23falseiso4217:GBPxbrli:pure074303972025-01-31074303972026-01-31074303972025-02-012026-01-31074303972024-01-31074303972025-01-31074303972024-02-012025-01-3107430397bus:SmallEntities2025-02-012026-01-3107430397bus:AuditExempt-NoAccountantsReport2025-02-012026-01-3107430397bus:FullAccounts2025-02-012026-01-3107430397bus:PrivateLimitedCompanyLtd2025-02-012026-01-3107430397core:WithinOneYear2026-01-3107430397core:AfterOneYear2026-01-3107430397core:WithinOneYear2025-01-3107430397core:AfterOneYear2025-01-3107430397core:ShareCapital2026-01-3107430397core:SharePremium2026-01-3107430397core:RevaluationReserve2026-01-3107430397core:OtherReservesSubtotal2026-01-3107430397core:RetainedEarningsAccumulatedLosses2026-01-3107430397core:ShareCapital2025-01-3107430397core:SharePremium2025-01-3107430397core:RevaluationReserve2025-01-3107430397core:OtherReservesSubtotal2025-01-3107430397core:RetainedEarningsAccumulatedLosses2025-01-3107430397core:LandBuildings2026-01-3107430397core:PlantMachinery2026-01-3107430397core:Vehicles2026-01-3107430397core:FurnitureFittings2026-01-3107430397core:OfficeEquipment2026-01-3107430397core:NetGoodwill2026-01-3107430397core:IntangibleAssetsOtherThanGoodwill2026-01-3107430397core:ListedExchangeTraded2026-01-3107430397core:UnlistedNon-exchangeTraded2026-01-3107430397core:LandBuildings2025-01-3107430397core:PlantMachinery2025-01-3107430397core:Vehicles2025-01-3107430397core:FurnitureFittings2025-01-3107430397core:OfficeEquipment2025-01-3107430397core:NetGoodwill2025-01-3107430397core:IntangibleAssetsOtherThanGoodwill2025-01-3107430397core:ListedExchangeTraded2025-01-3107430397core:UnlistedNon-exchangeTraded2025-01-3107430397core:LandBuildings2025-02-012026-01-3107430397core:PlantMachinery2025-02-012026-01-3107430397core:Vehicles2025-02-012026-01-3107430397core:FurnitureFittings2025-02-012026-01-3107430397core:OfficeEquipment2025-02-012026-01-3107430397core:NetGoodwill2025-02-012026-01-3107430397core:IntangibleAssetsOtherThanGoodwill2025-02-012026-01-3107430397core:ListedExchangeTraded2025-02-012026-01-3107430397core:UnlistedNon-exchangeTraded2025-02-012026-01-3107430397core:MoreThanFiveYears2025-02-012026-01-3107430397core:Non-currentFinancialInstruments2026-01-3107430397core:Non-currentFinancialInstruments2025-01-3107430397dpl:CostSales2025-02-012026-01-3107430397dpl:DistributionCosts2025-02-012026-01-3107430397core:LandBuildings2025-02-012026-01-3107430397core:PlantMachinery2025-02-012026-01-3107430397core:Vehicles2025-02-012026-01-3107430397core:FurnitureFittings2025-02-012026-01-3107430397core:OfficeEquipment2025-02-012026-01-3107430397dpl:AdministrativeExpenses2025-02-012026-01-3107430397core:NetGoodwill2025-02-012026-01-3107430397core:IntangibleAssetsOtherThanGoodwill2025-02-012026-01-3107430397dpl:GroupUndertakings2025-02-012026-01-3107430397dpl:ParticipatingInterests2025-02-012026-01-3107430397dpl:GroupUndertakingscore:ListedExchangeTraded2025-02-012026-01-3107430397core:ListedExchangeTraded2025-02-012026-01-3107430397dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-02-012026-01-3107430397core:UnlistedNon-exchangeTraded2025-02-012026-01-3107430397dpl:CostSales2024-02-012025-01-3107430397dpl:DistributionCosts2024-02-012025-01-3107430397core:LandBuildings2024-02-012025-01-3107430397core:PlantMachinery2024-02-012025-01-3107430397core:Vehicles2024-02-012025-01-3107430397core:FurnitureFittings2024-02-012025-01-3107430397core:OfficeEquipment2024-02-012025-01-3107430397dpl:AdministrativeExpenses2024-02-012025-01-3107430397core:NetGoodwill2024-02-012025-01-3107430397core:IntangibleAssetsOtherThanGoodwill2024-02-012025-01-3107430397dpl:GroupUndertakings2024-02-012025-01-3107430397dpl:ParticipatingInterests2024-02-012025-01-3107430397dpl:GroupUndertakingscore:ListedExchangeTraded2024-02-012025-01-3107430397core:ListedExchangeTraded2024-02-012025-01-3107430397dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-02-012025-01-3107430397core:UnlistedNon-exchangeTraded2024-02-012025-01-3107430397core:NetGoodwill2026-01-3107430397core:IntangibleAssetsOtherThanGoodwill2026-01-3107430397core:LandBuildings2026-01-3107430397core:PlantMachinery2026-01-3107430397core:Vehicles2026-01-3107430397core:FurnitureFittings2026-01-3107430397core:OfficeEquipment2026-01-3107430397core:AfterOneYear2026-01-3107430397core:WithinOneYear2026-01-3107430397core:ListedExchangeTraded2026-01-3107430397core:UnlistedNon-exchangeTraded2026-01-3107430397core:ShareCapital2026-01-3107430397core:SharePremium2026-01-3107430397core:RevaluationReserve2026-01-3107430397core:OtherReservesSubtotal2026-01-3107430397core:RetainedEarningsAccumulatedLosses2026-01-3107430397core:NetGoodwill2025-01-3107430397core:IntangibleAssetsOtherThanGoodwill2025-01-3107430397core:LandBuildings2025-01-3107430397core:PlantMachinery2025-01-3107430397core:Vehicles2025-01-3107430397core:FurnitureFittings2025-01-3107430397core:OfficeEquipment2025-01-3107430397core:AfterOneYear2025-01-3107430397core:WithinOneYear2025-01-3107430397core:ListedExchangeTraded2025-01-3107430397core:UnlistedNon-exchangeTraded2025-01-3107430397core:ShareCapital2025-01-3107430397core:SharePremium2025-01-3107430397core:RevaluationReserve2025-01-3107430397core:OtherReservesSubtotal2025-01-3107430397core:RetainedEarningsAccumulatedLosses2025-01-3107430397core:NetGoodwill2024-01-3107430397core:IntangibleAssetsOtherThanGoodwill2024-01-3107430397core:LandBuildings2024-01-3107430397core:PlantMachinery2024-01-3107430397core:Vehicles2024-01-3107430397core:FurnitureFittings2024-01-3107430397core:OfficeEquipment2024-01-3107430397core:AfterOneYear2024-01-3107430397core:WithinOneYear2024-01-3107430397core:ListedExchangeTraded2024-01-3107430397core:UnlistedNon-exchangeTraded2024-01-3107430397core:ShareCapital2024-01-3107430397core:SharePremium2024-01-3107430397core:RevaluationReserve2024-01-3107430397core:OtherReservesSubtotal2024-01-3107430397core:RetainedEarningsAccumulatedLosses2024-01-3107430397core:AfterOneYear2025-02-012026-01-3107430397core:WithinOneYear2025-02-012026-01-3107430397core:Non-currentFinancialInstrumentscore:CostValuation2025-02-012026-01-3107430397core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-02-012026-01-3107430397core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-02-012026-01-3107430397core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-02-012026-01-3107430397core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-02-012026-01-3107430397core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-02-012026-01-3107430397core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-02-012026-01-3107430397core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-02-012026-01-3107430397core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-02-012026-01-3107430397core:Non-currentFinancialInstrumentscore:CostValuation2026-01-3107430397core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-01-3107430397core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-01-3107430397core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-01-3107430397core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-01-3107430397core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-01-3107430397core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2026-01-3107430397core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-01-3107430397core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-01-3107430397core:Non-currentFinancialInstrumentscore:CostValuation2025-01-3107430397core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-01-3107430397core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-01-3107430397core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-01-3107430397core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-01-3107430397core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-01-3107430397core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-01-3107430397core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-01-3107430397core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-01-3107430397bus:Director12025-02-012026-01-3107430397bus:Director22025-02-012026-01-31

MEDS AT HOME LIMITED

Registered Number
07430397
(England and Wales)

Unaudited Financial Statements for the Year ended
31 January 2026

MEDS AT HOME LIMITED
Company Information
for the year from 1 February 2025 to 31 January 2026

Directors

HUSSAIN, Ashraf
IQBAL, Amjid

Registered Address

Unit 26 Delph Industrial Estate, Delph Road
Brierley Hill
DY5 2UA

Registered Number

07430397 (England and Wales)
MEDS AT HOME LIMITED
Balance Sheet as at
31 January 2026

Notes

2026

2025

£

£

£

£

Fixed assets
Tangible assets31,4051,372
1,4051,372
Current assets
Stocks442,83538,481
Debtors5133,229176,231
Cash at bank and on hand25,9219,918
201,985224,630
Creditors amounts falling due within one year6(137,001)(154,143)
Net current assets (liabilities)64,98470,487
Total assets less current liabilities66,38971,859
Net assets66,38971,859
Capital and reserves
Called up share capital100100
Profit and loss account66,28971,759
Shareholders' funds66,38971,859
The financial statements were approved and authorised for issue by the Board of Directors on 23 July 2026, and are signed on its behalf by:
HUSSAIN, Ashraf
Director
IQBAL, Amjid
Director

Registered Company No. 07430397
MEDS AT HOME LIMITED
Notes to the Financial Statements
for the year ended 31 January 2026

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Straight line (years)
Office Equipment4
Stocks and work in progress
Inventories are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).
2.Average number of employees

20262025
Average number of employees during the year68
3.Tangible fixed assets

Land & buildings

Plant & machinery

Office Equipment

Total

££££
Cost or valuation
At 01 February 251,86837,19643,30382,367
Additions--365365
At 31 January 261,86837,19643,66882,732
Depreciation and impairment
At 01 February 251,86837,19641,93180,995
Charge for year--332332
At 31 January 261,86837,19642,26381,327
Net book value
At 31 January 26--1,4051,405
At 31 January 25--1,3721,372
4.Stocks

2026

2025

££
Raw materials and consumables42,83538,481
Total42,83538,481
5.Debtors: amounts due within one year

2026

2025

££
Trade debtors / trade receivables120,828154,395
Other debtors11,14717,222
Prepayments and accrued income1,2544,614
Total133,229176,231
6.Creditors: amounts due within one year

2026

2025

££
Trade creditors / trade payables68,72690,349
Bank borrowings and overdrafts5,000-
Taxation and social security1,4796,382
Payments received on account51,30849,326
Other creditors10,4888,086
Total137,001154,143
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.